During this training participants will learn about the available medications for people with opioid use disorder and other substance use disorders and their efficacy. It will talk about the risks and benefits of treatment with various medications, the underlying neurobiology of relapse and what we know about how medications target those circuits, and the role
Mile Square Health Center and Family Guidance Center (FGC) has developed an integrated collaborative model that offers access to comprehensive behavioral health and MAR services in the primary care clinic. The program includes all three of the FDA approved medications, methadone, buprenorphine/naloxone, and naltrexone for those patients with OUD. Mile Square and FGC team members will
Course Objectives: Screen and identify patients with OUD and define evidence-based treatments. Discuss the pharmacology of opioids as it relates to treatment of opioid use disorder (OUD) patients. Describe the fundamentals of office-based opioid treatment including the treatment of the co-morbid patient. Explain the process of buprenorphine induction as well as stabilization and maintenance. Discuss
Please save the date for an in-person conference on April 20th, taking place at the Bloomington-Normal Marriot Hotel in Bloomington, IL, for the Illinois Learning Collaborative to Support Medication Assisted Recovery Implementation for Justice-Involved Populations. Please note that this event is open and free to all individuals interested in attendance with advance registration. Highlights from
This content includes three presentations that share the speakers' stories of substance use disorder lived experience, including experiences with stigma, harm reduction methods, and medications for opioid use disorder (MOUD) / Medication-Assisted Treatment (MAT) as best practice when possible. A Naloxone training, provided by the Egyptian Health Department, concludes the material. The goal is to
As we continue to respond to the rapidly evolving opioid epidemic, this session will provide current state information on fentanyl and xylazine, which is now present in the Illinois drug supply. This session will be informed by the latest data on effective approaches to education, prevention, and treatment for opioid use disorder (OUD), incorporating the
The 2023 ICAHN Opioid Conference, End the Stigma: Addressing Substance Abuse Disorder, will be Tuesday, June 27 at the I-Hotel and Conference Center, Champaign. Expert presenters and panels will discuss action steps you can use today to improve outcomes in your community. Special focus will be on supporting the lived experience.
Health Management Associates (HMA) is partnering with the Illinois Department of Human Services Division of Substance Use Prevention and Recovery (IDHS SUPR) to provide technical assistance and grants to Illinois counties to implement Medication Assisted Recovery (MAR) for persons with opioid use disorder in county jails and to support reentry. The program also focuses on
The purpose of the Supporting Medication Assisted Recovery (MAR): Mental Health and MOUD Medications webinar is to increase knowledge among non-prescribers in the assessment and treatment of medication assisted recovery as related to mental health and MOUD medications. This 1.5-hour webinar session will be led by Rush Associate Professor and SUD-COE Director, Tanya Sorrell. This
Please save the date for an in-person conference on December 6th, taking place at the Peoria Marriot Père Marquette in Peoria, IL, for the Illinois Learning Collaborative to Support Medication Assisted Recovery Implementation for Justice-Involved Populations. Please note that this event is open and free to all individuals interested in attendance with advance registration. Highlights